Experience with tecarfarin, a novel vitamin K antagonist: use with reversing agents and in mechanical heart valve recipients

Back

ESC Premium Access

Experience with tecarfarin, a novel vitamin K antagonist: use with reversing agents and in mechanical heart valve recipients

Session: Poster session 4 - Thrombosis and coagulation

Topic: Thrombosis and coagulation

Speaker: Doctor M. Midei (Monkton, US)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Mark Midei

Armetheon, Monkton (United States of America)

0 follower

9 more presentations in this session

Elevated lipoprotein a levels in patients with prosthetic valve thrombosis

Speaker: Professor M. Ozkan (Istanbul, TR)

Access

Abstract

Slides

Concentration dependent effects of edoxaban on thrombin generation kinetics and physical characteristics of clot By CAT and TEG6 assay

Speaker: Doctor U. Tantry

Access

Abstract

Slides

Demographic and clinical characteristics associated with initiation of individual oral anticoagulants among patients with newly diagnosed venous thromboembolism

Speaker: Doctor X. Li (Princeton, US)

Access

Abstract

Slides

Management of deep vein thrombosis in a multidisciplinary team

Speaker: Doctor A. Albertsen (Viborg, DK)

Access

Abstract

Slides

Cancer, chronic kidney disease and thrombosis.

Speaker: Professor I. Elalamy (Paris, FR)

Access

Abstract

Slides

Access the full session

Poster session 4 - Thrombosis and coagulation

Speakers: Doctor M. Midei, Professor M. Ozkan, Doctor U. Tantry, Doctor X. Li, Doctor A. Albertsen...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources